112 related articles for article (PubMed ID: 10995012)
1. Amifostine (WR-2721) selective protection against melphalan genotoxicity.
Buschini A; Anceschi E; Carlo-Stella C; Regazzi E; Rizzoli V; Poli P; Rossi C
Leukemia; 2000 Sep; 14(9):1642-51. PubMed ID: 10995012
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells.
Buschini A; Alessandrini C; Martino A; Pasini L; Rizzoli V; Carlo-Stella C; Poli P; Rossi C
Biochem Pharmacol; 2002 Mar; 63(5):967-75. PubMed ID: 11911849
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of amifostine on busulfan induced DNA damage in human hepatoma cells.
Ghassemi-Barghi N; Etebari M; Jafarian-Dehkordi A
Toxicol Mech Methods; 2017 Jan; 27(1):52-57. PubMed ID: 27771991
[TBL] [Abstract][Full Text] [Related]
4. Differential antigenotoxic and cytoprotective effect of amifostine in idarubicin-treated mice.
de Campos Nebel M; Larripa I; González-Cid M
Environ Mol Mutagen; 2002; 39(1):3-9. PubMed ID: 11813290
[TBL] [Abstract][Full Text] [Related]
5. Systemic chemotherapy-induced microsatellite instability in the mononuclear cell fraction of women with breast cancer can be reproduced in vitro and abrogated by amifostine.
Pinto JL; Fonseca FL; Marsicano SR; Delgado PO; Sant'anna AV; Coelho PG; Maeda P; Del Giglio A
J Pharm Pharmacol; 2010 Jul; 62(7):931-4. PubMed ID: 20636882
[TBL] [Abstract][Full Text] [Related]
6. Amifostine can differentially modulate DNA double-strand breaks and apoptosis induced by idarubicin in normal and cancer cells.
Wozniak K; Gloc E; Morawiec Z; Blasiak J
Exp Oncol; 2008 Mar; 30(1):22-8. PubMed ID: 18438337
[TBL] [Abstract][Full Text] [Related]
7. Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) test.
Aydemir N; Sevim N; Celikler S; Vatan O; Bilaloglu R
Mutat Res; 2009; 679(1-2):1-5. PubMed ID: 19712749
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the action of amifostine and melatonin on DNA-damaging effects and apoptosis induced by idarubicin in normal and cancer cells.
Majsterek I; Gloc E; Blasiak J; Reiter RJ
J Pineal Res; 2005 May; 38(4):254-63. PubMed ID: 15813902
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine.
Błasiak J; Gloc E; Woźniak K; Młynarski W; Stolarska M; Skórski T; Majsterek I
Chem Biol Interact; 2002 Apr; 140(1):1-18. PubMed ID: 12044557
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity and antimutagenicity studies of DRDE-07 and its analogs against sulfur mustard in the in vitro Ames Salmonella/microsome assay.
Vijayan V; Pathak U; Meshram GP
Mutat Res Genet Toxicol Environ Mutagen; 2014 Oct; 773():39-45. PubMed ID: 25308705
[TBL] [Abstract][Full Text] [Related]
11. The potential of amifostine: from cytoprotectant to therapeutic agent.
Santini V; Giles FJ
Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
[TBL] [Abstract][Full Text] [Related]
12. Amifostine for protection from antineoplastic drug toxicity.
Foster-Nora JA; Siden R
Am J Health Syst Pharm; 1997 Apr; 54(7):787-800. PubMed ID: 9099346
[TBL] [Abstract][Full Text] [Related]
13. Anticlastogenic effect of S-2-(3-aminopropylamino) ethylphosphorothioic acid against X-rays in mice.
Mazur L
Physiol Res; 1996; 45(1):59-63. PubMed ID: 8884925
[TBL] [Abstract][Full Text] [Related]
14. Radioprotective effects of amifostine in vitro and in vivo measured with the comet assay.
Müller AC; Pigorsch S; Beyer C; Lautenschläger C; Dunst J
Strahlenther Onkol; 2004 Aug; 180(8):517-25. PubMed ID: 15292973
[TBL] [Abstract][Full Text] [Related]
15. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action.
Grdina DJ; Shigematsu N; Dale P; Newton GL; Aguilera JA; Fahey RC
Carcinogenesis; 1995 Apr; 16(4):767-74. PubMed ID: 7728953
[TBL] [Abstract][Full Text] [Related]
16. Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow.
Mazur L; Augustynek A; Deptała A; Halicka HD; Bedner E
Anticancer Drugs; 2002 Aug; 13(7):751-8. PubMed ID: 12187332
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.
Adamson PC; Balis FM; Belasco JE; Lange B; Berg SL; Blaney SM; Craig C; Poplack DG
Cancer Res; 1995 Sep; 55(18):4069-72. PubMed ID: 7664282
[TBL] [Abstract][Full Text] [Related]
18. Melphalan-induced DNA damage in p53(+/-) and wild type mice analysed by the comet assay.
Cordelli E; Cinelli S; Lascialfari A; Ranaldi R; Pacchierotti F
Mutat Res; 2004 Jun; 550(1-2):133-43. PubMed ID: 15135647
[TBL] [Abstract][Full Text] [Related]
19. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects.
van der Vijgh WJ; Peters GJ
Semin Oncol; 1994 Oct; 21(5 Suppl 11):2-7. PubMed ID: 7973774
[TBL] [Abstract][Full Text] [Related]
20. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
Murray D; Altschuler EM; Hunter N; Milas L
Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
